Page last updated: 2024-11-07

androsterone and Diabetes Mellitus, Type 2

androsterone has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Another pandemic disease is type II diabetes mellitus (T2D) that is estimated to affect half a billion people in the world."5.6216α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment. ( Baay-Guzman, G; Barrios-Payan, JA; Bini, E; Carranza, A; Chamberlin, W; Ge, Y; Hernández-Pando, R; López-Torres, MO; Marquina-Castillo, B; Mata-Espinosa, D; Ramos-Espinosa, O; Torre-Villalvazo, I; Torres, N; Tovar, A; Yepez, SH, 2021)
"Another pandemic disease is type II diabetes mellitus (T2D) that is estimated to affect half a billion people in the world."1.6216α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment. ( Baay-Guzman, G; Barrios-Payan, JA; Bini, E; Carranza, A; Chamberlin, W; Ge, Y; Hernández-Pando, R; López-Torres, MO; Marquina-Castillo, B; Mata-Espinosa, D; Ramos-Espinosa, O; Torre-Villalvazo, I; Torres, N; Tovar, A; Yepez, SH, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
López-Torres, MO1
Marquina-Castillo, B1
Ramos-Espinosa, O1
Mata-Espinosa, D1
Barrios-Payan, JA1
Baay-Guzman, G1
Yepez, SH1
Bini, E1
Torre-Villalvazo, I1
Torres, N1
Tovar, A1
Chamberlin, W1
Ge, Y1
Carranza, A1
Hernández-Pando, R1

Other Studies

1 other study available for androsterone and Diabetes Mellitus, Type 2

ArticleYear
16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
    Clinical and experimental immunology, 2021, Volume: 205, Issue:2

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Androsterone; Animals; Antitubercular Agents; Comorbidity; Co

2021